Patent details

Basic Information

Publication number:

EP1250138

PCT Application Number:

PCT/GB/2001/000049

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP019001866

PCT Publication Number:

WO/2001/051056

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

FULVESTRANT FORMULATION

French Title of Invention:

PREPARATION DE FULVESTRANT

German Title of Invention:

FULVESTRANT FORMULIERUNG

SPC Number:

Dates

Filing date:

08/01/2001

Grant date:

19/10/2005

EP Publication Date:

19/10/2005

PCT Publication Date:

19/07/2001

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

23/10/2002

EP B1 Publication Date:

19/10/2005

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

08/01/2021

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

08/01/2001

 

 

Name:

AstraZeneca AB

Address:

-, 151 85 Södertälje, Sweden (SE)

Agent

Name:

VAN MALDEREN MICHEL

From:

05/12/2005

Address:

ROUTE D'ARLON 261, 8002, STRASSSEN, Luxembourg (LU)

To:

Inventor

1

Name:

GRUNDY Rosalind, Ursula

Address:

United Kingdom (GB)

2

Name:

EVANS John, Raymond

Address:

United Kingdom (GB)

Priority

1

Priority Number:

0000313

Priority Date:

10/01/2000

Priority Country:

United Kingdom (GB)

2

Priority Number:

0008837

Priority Date:

12/04/2000

Priority Country:

United Kingdom (GB)

Classification

Main IPC Class:

A61K 31/565;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

24/12/2019

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages